ETH Zuerich - Homepage
Herzlich Willkommen
Deutsch English

Regulatory Affairs


"The Regulatory Affairs course is very well structured, with detailed information about the Swiss and international regulatory fields. The gained knowledge is highly useful and applicable to the daily work."

Dr. Sandrine Beier, Manager Regulatory Affairs, TRB Chemedica International SA

Dr. Sandrine Beier


This course provides an integrated view of drug regulation in the US, Europe and Switzerland. The goal is to offer an introduction to regulatory affairs in order to understand the legal basis and its implications for drug development and production.

In particular, the following topics will be covered: organization of European and Swiss authorities and their main regulations, the implications of drug regulation for pharmaceutical and clinical development, marketing authorization procedures and post-marketing procedures. Furthermore the course will teach particularities of drug regulation in Switzerland and the respective adaptation of regulatory documents.

Regulatory aspects of special medicinal products such as generics, biosimilars, orphan and herbal medicinal products will also be highlighted.

The speakers include experts from industry, consulting and the health authorities.


The course addresses individuals with a degree in pharmacy, medicine or natural sciences who work in the pharmaceutical or a related industry or for a service provider in this field. In particular:

Topics and speakers 2015

Opening lecture:

Regulatory aspects of drug development

Dr. L. Ham, F. Hoffmann-La Roche
European regulations for medicinal products, ICH, CTD Dr. F. Wierckx, Clinipace
Marketing authorisation in the EU
S. Ruini, Pharma Design Limited
FDA regulations
G. Maitra, AC Immune
Pharmacovigilance K. Hartmann, WHO mandates
Clinical trial directives and application procedures
Dr. B. Happ, consultant
Health economics and outcomes research
Dr. M. Olson, Novartis
Swiss authorities and regulations C. Landgraf, Swissmedic
Helvetisation of regulatory documents
Dr. B. Zimmerli Matter, PCR
Special regulations: Biologics
Dr. L. Ham, F. Hoffmann-La Roche
Special regulations: Generics
M. Lieberherr, Streuli Pharma
Special regulations: Biosimilars
Dr. U. Gosslar, Sandoz
Special regulations: Orphan Drugs
Dr. P. Herrmann, Actelion
Special regulations: Paediatrics Dr. P. Montavon, Roche
Special regulations: GMOs and advanced therapeutics incl. gene therapy
Dr. G. Perrin, PaxVax Berna
Special regulations: Companion diagnostics
Dr. M. C. Beurier, Roche
Variations and change control
Dr. D. Brandt, Acino Pharma
Electronic submission
Dr. M. Braun, Exalon GmbH
Workshop :

How to search the web for regulatory information

Dr. D. Heer, Armeeapotheke

Course language



planned for June 2017 (5 days)

from 9 am to 5 pm

Course location

Pharmacy museum, Totengässlein, Basel, University of Basel

Course fee

CHF 2500.-
reduced price for PhD students


Application Form »»


Wichtiger Hinweis:
Diese Website wird in älteren Versionen von Netscape ohne graphische Elemente dargestellt. Die Funktionalität der Website ist aber trotzdem gewährleistet. Wenn Sie diese Website regelmässig benutzen, empfehlen wir Ihnen, auf Ihrem Computer einen aktuellen Browser zu installieren. Weitere Informationen finden Sie auf
folgender Seite.

Important Note:
The content in this site is accessible to any browser or Internet device, however, some graphics will display correctly only in the newer versions of Netscape. To get the most out of our site we suggest you upgrade to a newer browser.
More information

© 2015 ETH Zurich | Imprint | Disclaimer | 18 June 2015